Trial Profile
A Randomized, Placebo Controlled, Single Center Clinical Trial for Evaluation of Efficacy and Safety of Sildenafil Administration in the Cardiac ICU Following Mitral Valve Surgery in Patients With Pulmonary Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 24 Jun 2018 Status changed from recruiting to completed.
- 17 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.
- 17 Apr 2016 Planned End Date changed from 1 Mar 2017 to 1 Oct 2017.